Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Home Newsfeeds HC Wainwright & Co. Downgrades Vyant Bio to Neutral

HC Wainwright & Co. Downgrades Vyant Bio to Neutral

HC Wainwright & Co. analyst Edward White downgrades Vyant Bio (NASDAQ:VYNT) from Buy to Neutral.

byBenzinga Newsdesk

February 3, 2023

1 minute read

HC Wainwright & Co. analyst Edward White downgrades Vyant Bio (NASDAQ:VYNT) from Buy to Neutral.

‘Foresight And Global Japanese Vehicle Manufacturer Will Work Together To Resolve Camera Miscalibration Issues’

By Happy Mohamed

March 6, 9:37 AM

https://maya.tase.co.il/en/reports/details/1509447/2/0

FRSX

News

Overview Of Value Stocks In The Consumer Cyclical Sector

By Benzinga Insights

July 25, 10:43 AM

What is a Value Stock? A value stock is traditionally defined in terms of how investors in the…

DDS

Fusion Pharma Raises $60M To Fund Acquisition Of Prostate Cancer-Targeted Radiopharmaceutical

By Vandana Singh

February 14, 8:59 AM

Fusion Pharmaceuticals Inc (NASDAQ:FUSN) acquired the investigational new drug application for an ongoing Phase 2 TATCIST trial evaluating 225Ac-PSMA…

FUSN

Fed’s Kashkari Says U.S. Economy Is Sending Wildly Mixed Signals; Says Fed’s Job Is To Keep Inflation In Check; Says This Is Not Wage-Driving Inflation; Says This Inflation Is From Demand, And Constrained Supply

By Benzinga Newsdesk

November 17, 2:52 PM

-Reuters

SPY

HC Wainwright & Co. Downgrades Vyant Bio to Neutral

Related Posts

‘Foresight And Global Japanese Vehicle Manufacturer Will Work Together To Resolve Camera Miscalibration Issues’

Overview Of Value Stocks In The Consumer Cyclical Sector

Fusion Pharma Raises $60M To Fund Acquisition Of Prostate Cancer-Targeted Radiopharmaceutical

Fed’s Kashkari Says U.S. Economy Is Sending Wildly Mixed Signals; Says Fed’s Job Is To Keep Inflation In Check; Says This Is Not Wage-Driving Inflation; Says This Inflation Is From Demand, And Constrained Supply